Publication | Closed Access

Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II: A Gynecologic Oncology Group study

Gynecologic SurgerySurgical OncologyGynecological SurgeryRadiation TherapyMedicineCancer ManagementGynecologyHigh-risk Endometrial CarcinomaCancer TreatmentOncologyRadiation OncologyGynecology Oncology